Home > News > Chicago-ITEC Makes Additional Investments
April 5th, 2004
Chicago-ITEC Makes Additional Investments
The Chicago Illinois Technology Enterprise Center (Chicago-ITEC) today announced four new additions to their portfolio of life sciences and technology companies. Investments were made in Genomics USA, Inc.; Immune Cell Therapy, Inc.; Lambda Vision, Inc; and DermaAegis, Inc. These new investments bring the total number of companies in which Chicago-ITEC has invested to ten.
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Harris & Harris Group Portfolio Company OpGen Files Amended Registration Statement for Proposed Public Offering April 8th, 2015
Harris & Harris Group Reports Financial Statements as of December 31, 2014 and Posts Annual Letter to Shareholders on Website March 17th, 2015